A New Zealand biotech firm will implant insulin-producing pig cells on into eight diabetics as part of its continuing test of the new treatment for Type 1 diabetes.
Volunteer patients at the Middlemore Hospital in Auckland will be implanted with Living Cell Technologies' branded Diabecell in their abdomens, where it will secrete pig insulin to control their blood sugar levels. With the implants, the patient need not get insulin by injection.